TP53 and breast cancer: Compared with HER2‐low breast cancer, HER2‐negative tumors are associated with higher mutation rates in tumor suppressor genes and proto‐oncogenes such as TP53, TERT, GALNT12, CARD11, and TRRAP, which promote extensive tumor cell proliferation [6].